| High-dose chemotherapy of breast cancer: is the question answered? |
| MJ Kennedy |
|
JCO Oct 1 1995: 2477–2479.
[PDF]
|
 |
| CNS chemoradiotherapy of childhood leukemia: the plot thickens but the ending bodes well |
| A Bleyer |
|
JCO Oct 1 1995: 2480–2482.
[PDF]
|
|
|
High-dose chemotherapy with hematopoietic rescue as primary treatment for metastatic breast cancer: a randomized trial |
| |
WR Bezwoda, L Seymour, and RD Dansey |
| |
JCO Oct 1 1995: 2483–2489.
[Abstract]
[PDF]
|
|
|
Cognitive sequelae of treatment in childhood acute lymphoblastic leukemia: cranial radiation requires an accomplice |
| |
DP Waber, NJ Tarbell, D Fairclough, K Atmore, R Castro, P Isquith, F Lussier, I Romero, PJ Carpenter, and M Schiller |
| |
JCO Oct 1 1995: 2490–2496.
[Abstract]
[PDF]
|
|
|
Extended intrathecal methotrexate may replace cranial irradiation for prevention of CNS relapse in children with intermediate-risk acute lymphoblastic leukemia treated with Berlin-Frankfurt-Munster-based intensive chemotherapy. The Associazione Italiana di Ematologia ed Oncologia Pediatrica |
| |
V Conter, M Arico, MG Valsecchi, C Rizzari, AM Testi, C Messina, PG Mori, R Miniero, R Colella, and G Basso |
| |
JCO Oct 1 1995: 2497–2502.
[Abstract]
[PDF]
|
|
|
Pubertal growth in young adult survivors of childhood leukemia |
| |
E Didcock, HA Davies, M Didi, AL Ogilvy Stuart, JK Wales, and SM Shalet |
| |
JCO Oct 1 1995: 2503–2507.
[Abstract]
[PDF]
|
|
|
Anaphylactoid reactions in children receiving high-dose intravenous cyclosporine for reversal of tumor resistance: the causative role of improper dissolution of Cremophor EL |
| |
JG Theis, M Liau-Chu, HS Chan, J Doyle, ML Greenberg, and G Koren |
| |
JCO Oct 1 1995: 2508–2516.
[Abstract]
[PDF]
|
|
|
All-trans retinoic acid pharmacokinetics and bioavailability in acute promyelocytic leukemia: intracellular concentrations and biologic response relationship |
| |
A Agadir, M Cornic, P Lefebvre, B Gourmel, M Jerome, L Degos, P Fenaux, and C Chomienne |
| |
JCO Oct 1 1995: 2517–2523.
[Abstract]
[PDF]
|
|
|
Efficacy of single-agent chemotherapy in low-grade B-cell mucosa- associated lymphoid tissue lymphoma with prominent gastric expression |
| |
P Hammel, C Haioun, MT Chaumette, P Gaulard, M Divine, F Reyes, and JC Delchier |
| |
JCO Oct 1 1995: 2524–2529.
[Abstract]
[PDF]
|
|
|
Comparison of doxorubicin and mitoxantrone in the treatment of elderly patients with advanced diffuse non-Hodgkin's lymphoma using CHOP versus CNOP chemotherapy |
| |
P Sonneveld, M de Ridder, H van der Lelie, K Nieuwenhuis, H Schouten, A Mulder, I van Reijswoud, W Hop, and B Lowenberg |
| |
JCO Oct 1 1995: 2530–2539.
[Abstract]
[PDF]
|
|
|
Incidence of human immunodeficiency virus-related and nonrelated malignancies in a large cohort of homosexual men |
| |
DW Lyter, J Bryant, R Thackeray, CR Rinaldo, and LA Kingsley |
| |
JCO Oct 1 1995: 2540–2546.
[Abstract]
[PDF]
|
|
|
Factors that influence collection and engraftment of autologous peripheral-blood stem cells |
| |
W Bensinger, F Appelbaum, S Rowley, R Storb, J Sanders, K Lilleby, T Gooley, T Demirer, K Schiffman, and C Weaver |
| |
JCO Oct 1 1995: 2547–2555.
[Abstract]
[PDF]
|
|
|
Randomized comparison of tamoxifen and two separate doses of toremifene in postmenopausal patients with metastatic breast cancer |
| |
DF Hayes, JA Van Zyl, A Hacking, L Goedhals, WR Bezwoda, JA Mailliard, SE Jones, CL Vogel, RF Berris, and I Shemano |
| |
JCO Oct 1 1995: 2556–2566.
[Abstract]
[PDF]
|
|
|
Randomized comparison of vinorelbine and melphalan in anthracycline- refractory advanced breast cancer |
| |
S Jones, E Winer, C Vogel, L Laufman, L Hutchins, M O'Rourke, B Lembersky, D Budman, J Bigley, and J Hohneker |
| |
JCO Oct 1 1995: 2567–2574.
[Abstract]
[PDF]
|
|
|
Phase II trial of paclitaxel by 3-hour infusion as initial and salvage chemotherapy for metastatic breast cancer |
| |
AD Seidman, A Tiersten, C Hudis, M Gollub, S Barrett, TJ Yao, J Lepore, T Gilewski, V Currie, and J Crown |
| |
JCO Oct 1 1995: 2575–2581.
[Abstract]
[PDF]
|
|
|
Serum cardiac troponin T levels during treatment of early-stage breast cancer |
| |
L Hughes-Davies, D Sacks, J Rescigno, S Howard, and J Harris |
| |
JCO Oct 1 1995: 2582–2584.
[Abstract]
[PDF]
|
|
|
Toxicity and efficacy of escalating dosages of recombinant human interleukin-6 after chemotherapy in patients with breast cancer or non- small-cell lung cancer |
| |
GJ Veldhuis, PH Willemse, DT Sleijfer, WT van der Graaf, HJ Groen, PC Limburg, NH Mulder, and EG de Vries |
| |
JCO Oct 1 1995: 2585–2593.
[Abstract]
[PDF]
|
|
|
Cisplatin plus etoposide with and without ifosfamide in extensive small- cell lung cancer: a Hoosier Oncology Group study |
| |
Sr Loehrer PJ, R Ansari, R Gonin, F Monaco, W Fisher, A Sandler, and LH Einhorn |
| |
JCO Oct 1 1995: 2594–2599.
[Abstract]
[PDF]
|
|
|
Increased resting energy expenditure and weight loss are related to a systemic inflammatory response in lung cancer patients |
| |
AJ Staal-van den Brekel, MA Dentener, AM Schols, WA Buurman, and EF Wouters |
| |
JCO Oct 1 1995: 2600–2605.
[Abstract]
[PDF]
|
|
|
Radiation pneumonitis following combined modality therapy for lung cancer: analysis of prognostic factors |
| |
M Roach, 3rd, DR Gandara, HS Yuo, PS Swift, S Kroll, DC Shrieve, WM Wara, L Margolis, and TL Phillips |
| |
JCO Oct 1 1995: 2606–2612.
[Abstract]
[PDF]
|
|
|
Doxifluridine and leucovorin: an oral treatment combination in advanced colorectal cancer |
| |
E Bajetta, M Colleoni, M Di Bartolomeo, R Buzzoni, F Bozzetti, R Doci, L Somma, F Cappuzzo, CG Stampino, and A Guenzi |
| |
JCO Oct 1 1995: 2613–2619.
[Abstract]
[PDF]
|
|
|
Effect of granulocyte-macrophage colony-stimulating factor on oral mucositis in head and neck cancer patients after cisplatin, fluorouracil, and leucovorin chemotherapy |
| |
KH Chi, CH Chen, WK Chan, KC Chow, SY Chen, SH Yen, JY Chao, CY Chang, and KY Chen |
| |
JCO Oct 1 1995: 2620–2628.
[Abstract]
[PDF]
|
|
|
Efficacy of lenograstim on hematologic tolerance to MAID chemotherapy in patients with advanced soft tissue sarcoma and consequences on treatment dose-intensity |
| |
BN Bui, B Chevallier, C Chevreau, I Krakowski, AM Peny, A Thyss, C Maugard- Louboutin, D Cupissol, P Fargeot, and F Bonichon |
| |
JCO Oct 1 1995: 2629–2636.
[Abstract]
[PDF]
|
|
|
Nonsteroidal antiinflammatory drugs for cancer pain: comparison between misoprostol and ranitidine in prevention of upper gastrointestinal damage |
| |
M Valentini, R Cannizzaro, M Poletti, R Bortolussi, A Fracasso, V Testa, M Sozzi, M Fornasarig, F Bortoluzzi, and I Grazioli |
| |
JCO Oct 1 1995: 2637–2642.
[Abstract]
[PDF]
|
|
|
Docetaxel |
| |
JE Cortes and R Pazdur |
| |
JCO Oct 1 1995: 2643–2655.
[Abstract]
[PDF]
|
|
|
Coherent view of non-Hodgkin's lymphoma |
| |
AC Aisenberg |
| |
JCO Oct 1 1995: 2656–2675.
[Abstract]
[PDF]
|
|
| Chemotherapy for colorectal carcinoma: observations regarding recent clinical trials using biochemical modulation |
| S Wadler and EL Schwartz |
|
JCO Oct 1 1995: 2676–2677.
[PDF]
|
|
| Optimal treatment for untreated patients with hairy cell leukemia? |
| X Troussard and G Flandrin |
|
JCO Oct 1 1995: 2677–2679.
[PDF]
|
|
| Response to 13-cis-retinoic acid plus interferon alfa-2a in two patients with therapy-refractory advanced renal cell carcinoma |
| J Buer, M Probst, A Ganser, and J Atzpodien |
|
JCO Oct 1 1995: 2679–2680.
[PDF]
|
|
